It is an integral event of international collaboration for leaders in trends of MD, in major diseases treatment; an platform to know and enter Chinese market, network with other delegates, deliver new products and advance understanding of the potential of new molecular diagnostics technologies.
★ Program at a Glance
BIT's 4th Annual Congress and Exposition of Molecular Diagnostics (CEMD) -Overcome Misinterpretation of Symptoms
Dr. Peter Maag, President, Novartis Diagnostics, USA
Dr. Achim Plum, Senior Vice President, Epigenomics AG, Germany
Dr.Charles R. Cantor, Founder andCSO, SEQUENOM, Inc., USA
Dr. Etienne-Emile Baulieu, Former President, French Academy of Sciences, France; Professor, National Academy of Sciences of the USA
Dr. Stephen D. Barnhill, CEO, Health Discovery Corporation, USA
Mr. Bob Parson,
Vice President, Pharmacoeconomics & Outcomes Research, Alere Inc., USA
Dr. Claude Wischik, Executive Chairman and Founder, TauRx Therapeutics,UK
Dr. Willy Valdivia,
CEO, Orion Integrated Biosciences, Inc., USA
Dr. Han Cao, Founder and CSO, BioNanomatrix, Inc, USA
Dr.Thomas Andrew Braun, CEO, Verisante Technology Inc., Canada
Dr. Todd Barry,
Medical Director and Hematopathologist, Clarient, USA
Dr. Zhong Chen, Professor, University of Utah ; CTO, China Medical Technologies, Inc., USA
Dr. James V. Snider,
President, Critical Diagnostics, USA
Dr. Herb Fritsche,
CSO, Health Discovery Corporation, USA
Dr. Ramesh Ramakrishnan, Director, Fluidigm Corp., USA
Dr.Xiaolian Gao, CSO, LC Sciences, USA
Dr. Giorgio Secreto,
Director of the Hormone Research Laboratory, Italy's National Cancer Institute, Italy
Dr. Jiahuan Ding,
Director and Professor, Baylor University Graduate School, USA
Dr. Axel M. Gressner, Professor, The German Society for Clinical Chemistry and Laboratory Medicine (DGKL), Germany
Dr. Junko Stevens, R&D Director, Life Technologies, USA
Dr.Hugo ten Cate, Professor, Department of Internal Medicine, University of Maastricht, The Netherlands
Dr.Fyllis Tafas, Founder and CTO, Ikonisys Inc., USA
Dr.Jean-Pol Detiffe,
Founder and CEO, DNAVISION SA, Belgium
Dr.Ira L. Goldknopf, President and CSO, Power3 Medical Products, Inc., USA
★ Past Event Report
BIT's 3rd Annual Congress and Expo of Molecular Diagnostics (CEMD-2010) was an important component of Molmed-2010.On November 10-12, 2010, BIT's 1st Annual Tetra-Congress of MolMed-2010 (MolMed-2010) with a theme of "From Molecular Structure to Functions" was held successfully in Shanghai Everbright Convention & Exhibition Center, Shanghai, China. More...
